Dante Labs Invests In UK To Apply Consumer Genome Sequencing To COVID-19 Variants
The L'Aquila, Italy-based company announced a £30m investment in global surveillance of new variants of the SARS-CoV-2 virus.
You may also be interested in...
Adaptive chief medical officer Lance Baldo talked to Medtech Insight about the company's plans to detect prior infection using T-cells obtained from blood samples.
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.